Filing Details
Cabaletta Bio, Inc. (NASDAQ:CABA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CABA
Cabaletta Bio, Inc. (CABA) Files Quarterly Report for Q0
Cabaletta Bio, Inc. (NASDAQ:CABA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
Cabaletta Bio, Inc. (NASDAQ:CABA) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Cabaletta Bio, Inc. (NASDAQ: CABA) filed its quarterly report (Form 10-Q) with the SEC on August 13, 2026.
- The company's stock trades at $2.71 with a market capitalization of $227.2 million.
- The 10-Q filing contains unaudited financial statements and management commentary on recent performance, including emerging trends and updated risk factors.
Market Context
Cabaletta Bio, Inc.'s stock currently trades at $2.71 with a market capitalization of $227.2M.
The 10-Q provides Cabaletta Bio, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Cabaletta Bio, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CABA Stock Page
Frequently Asked Questions
Where can I read CABA's SEC filings?
Browse all filings on our CABA SEC filings page.
What types of SEC filings does Cabaletta Bio, Inc. file?
Public companies like Cabaletta Bio, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.